Feasibility and device selection
Combined with primary package characterization, feasibility studies provide insights into device performance for informed decision-making.
How we do it
Feasibility studies and design assessment activities are initiated in the early development phases of device projects. This means that an informed characterization of the device design happens early, mitigating further risks and failures downstream of the device development process.
Primary package characterization
SHL Medical assists customers in quickly generating data to assess whether their drug and primary package align with their expectations. This involves characterization of the primary package, including functional testing and characterization of critical dimensions. Ultimately, the primary package characterization aims to support our customers in choosing the right primary package and de-risk costly implications during the lifecycle.
- Rapid provision of test results for improved decision-making
- Risk mitigation in terms of timeline and cost through early understanding of key specifications and device performance
- Convenience due to integration of testing service as part
of core offering, eliminating need for managing external supplier
![[.jpg] SHL-Medical DeerfieldBeach Final Assembly-Labelling 20250324 SitePhotos-8](https://cdn.bfldr.com/DTG6CG68/at/ktk9j65jr42qxsp9w4f79nrv/SHL-Medical_DeerfieldBeach_Final_Assembly-Labelling_20250324_SitePhotos-8.jpg?width=480&height=480&fit=crop&auto=webp&format=webp)
Feasibility studies
SHL Medical is committed to a holistic understanding of device performance, in order to support customers’ decision-making in choosing the right device. We offer functional testing, using your primary package with an existing SHL platform device to generate insight on how the combination product performs regarding specifications such as cap removal and activation force, injection depth, injection time, dose accuracy, and more.
In conjunction with Primary Package Characterization, feasibility studies results in a holistic understanding of the device and primary package performance, enabling customers to make the right decision for their combination product.
- Rapid provision of test results for improved decision-making
- Risk mitigation in terms of timeline and cost through early understanding of key specifications and device performance
- Convenience due to integration of testing service as part of core offering, eliminating the need for managing external supplier
Partner‑driven compatibility
We are proud to collaborate with innovators and leading suppliers in the pharmaceutical industry to ensure our devices are compatible with a wide range of primary containers. Read on to learn more about our recent collaborative studies, designed to provide our pharma partners with maximum flexibility and compatibility.
More Than the Sum of Its Parts: How Supplier Collaboration Drives Successful Combination Products - Download
Discover how the collaboration between SHL Medical, Gerresheimer, and Aptar Pharma supports the successful development of patient-centric combination products.
Proving the Design Space: Advancing the Development of Syringe-Device Combinations - Download
Explore how SHL Medical and Stevanato Group are mitigating integration risks and accelerating time to market through strategic collaboration.
Exploring Platform Synergies: Enabling High-Viscosity Biologic Delivery with SHL Medical's Molly 2.25 mL Autoinjector and Stevanato Group’s Syringes - Download
Learn how cross-platform integration through the combination of Stevanato Group’s portfolio of syringes and SHL’s Molly autoinjector broadens the platform design space for high-volume, high-viscosity biologics.
A Case Study on Expanding High Viscosity Performance Through Incremental Platform Modifications - Download
Explore how SHL Medical and BD are expanding high viscosity performance through incremental platform modifications
Curious to know more?
Covering the full drug delivery value chain, we provide peace of mind by offering end-to-end services.
Products
From custom projects to platform devices, we deliver self-injection solutions globally, supporting patients across diverse therapeutic areas.
Support services
Our quality, regulatory, and supply chain expertise is fully integrated into each device project to fulfill clinical, commercial, and aftermarket needs.